Dimethylformamide → HCID 22478209, compound
Reaction equation
[O:1]1[CH2:5][CH2:4][O:3][CH2:2]1.[Cl:6][C:7]1[CH:26]=[CH:25][C:10]([NH:11][C:12]2[C:21]3[C:16](=[CH:17][C:18](O)=[C:19]([O:22][CH3:23])[CH:20]=3)[N:15]=[CH:14][N:13]=2)=[C:9]([F:27])[CH:8]=1.[C:28](=[O:31])([O-])[O-].[K+].[K+].[CH3:34]N(C=O)C>>[Cl:6][C:7]1[CH:26]=[CH:25][C:10]([NH:11][C:12]2[C:21]3[C:16](=[CH:17][C:18]([O:31][CH2:28][CH2:34][CH:2]4[O:3][CH2:4][CH2:5][O:1]4)=[C:19]([O:22][CH3:23])[CH:20]=3)[N:15]=[CH:14][N:13]=2)=[C:9]([F:27])[CH:8]=1Participants
Conditions
- Temperature
- 100 °C
Procedure
A solution of 242-bromoethyl)-1,3-dioxolane (258 mg, 1.4 mmol) in DMF (0.5 ml) was added to a mixture of 4-(4-chloro-2-fluoroanilino)-7-hydroxy-6-methoxyquinazoline (329 mg, 1.02 mmol) and potassium carbonate (264 mg, 2 mmol) in DMF (2 ml). The mixture was heated at 100° C. for 3 hours and allowed to cool. The volatiles were removed by evaporation, and the residue partitioned between aqueous sodium hydrogen carbonate solution and methylene chloride. The organic phase was separated and passed through phase separating paper. The solvent was removed by evaporation, and the residue was purified by column chromatography eluting with methylene chloride/methanol (95/5) to give 4-(4-chloro-2-fluoroanilino)-7-(2(1,3-dioxolan-2-yl)ethoxy)-6-methoxyquinazoline (71 mg, 107%).
Workup
- temperatureto cool
- customThe volatiles were removed by evaporation
- customthe residue partitioned between aqueous sodium hydrogen carbonate solution and methylene chloride
- customThe organic phase was separated
- customseparating paper
- customThe solvent was removed by evaporation
- customthe residue was purified by column chromatography
- washeluting with methylene chloride/methanol (95/5)
Sources & evidence
- ORD record
- ord-80bc342df173435b90657dbe7f658067
- Source dataset
- uspto-grants-2005_05
- Patent number
- US06897210B2
Reaction notes
Loading…